The results of this meta-analysis demonstrate that serum IGF-1 levels were significantly higher in de novo, drug-naïve PD patients compared with healthy controls. Nevertheless, additional endeavors are required to further explore the association between serum IGF-1 levels and diagnosis, prognosis and early therapy for PD.
Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson’s Disease: A Meta-Analysis
About the Author: MedWorks
Related Posts
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave A Comment